Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacy-specific quality indicators for asthma therapy.

Almut G Winterstein1, Abraham G Hartzema

  • 1College of Pharmacy, Department of Pharmacy Healthcare Administration, University of Florida, PO Box 100496, Gainesville, FL 32610-0496, USA. almut@cop.ufl.edu

Research in Social & Administrative Pharmacy : RSAP
|December 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the quality of electronic health record data and the claims linked data for target trial emulation studies.

JAMIA open·2026
Same author

PEPRVision: a visualization framework for Pharmacoepidemiology research.

American journal of epidemiology·2026
Same author

Real-World Evidence for Drug Value Assessment in China: Learning from International Experiences.

Drugs - real world outcomes·2026
Same author

Effectiveness of THC-containing cannabis for inflammatory bowel disease: a systematic review.

Journal of cannabis research·2026
Same author

Joint Position Statement from the Society for Birth Defects Research and Prevention, the Organization of Teratology Information Specialists, and the Developmental Neurotoxicology Society: A Call for Implementation of Risk Evaluation and Mitigation Strategies to Reduce Prenatal Exposure to Valproate.

Birth defects research·2026
Same author

Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.

Drug safety·2026
Same journal

Mapping global evidence on pharmacy-based colorectal cancer screening initiatives in community settings: A scoping review.

Research in social & administrative pharmacy : RSAP·2026
Same journal

Effectiveness of a pharmacist-led protocol to manage cystitis in women, in France: the PharmaCyst' open-label, multicenter, randomized, controlled, cluster study.

Research in social & administrative pharmacy : RSAP·2026
Same journal

Factors associated with successful integration of pharmacists into residential aged care teams: A qualitative study.

Research in social & administrative pharmacy : RSAP·2026
Same journal

Automating the roter interaction analysis system for medication counseling: A transformer-based deep learning approach with generative AI-augmented data.

Research in social & administrative pharmacy : RSAP·2026
Same journal

Effect of a collaborative intervention by pharmacists and dentists on smoking cessation.

Research in social & administrative pharmacy : RSAP·2026
Same journal

Identifying stakeholder behaviors for competency-based pharmacy education: A stage 1 behavior change wheel analysis.

Research in social & administrative pharmacy : RSAP·2026
See all related articles

Pharmacies can now use new quality indicators to track asthma medication use and identify patients potentially overusing short-acting beta-agonists (SABAs). This helps improve asthma care and reduce emergency visits by flagging uncontrolled conditions.

Area of Science:

  • Pharmacoeconomics
  • Health Services Research
  • Clinical Pharmacy

Background:

  • Inappropriate asthma drug therapy is a significant quality issue, leading to preventable adverse events like emergency room visits and hospitalizations.
  • Existing quality indicators for asthma pharmacotherapy are not designed for pharmacy-level assessment.
  • There is a need for quality metrics applicable to retail pharmacies to monitor asthma care.

Purpose of the Study:

  • To develop and validate quality indicators for asthma care suitable for retail pharmacy settings.
  • To determine the prevalence of potentially inappropriate asthma medication use, specifically short-acting beta-agonist (SABA) overuse.
  • To analyze the variation in asthma care quality across different pharmacies.

Main Methods:

Related Experiment Videos

  • A descriptive analysis of dispensing data for beta-agonists and anti-inflammatory agents used for asthma was conducted over a 12-month period.
  • Two quality indicators were applied: (1) excessive supply of SABAs and (2) consecutive early refills of SABAs.
  • Pharmacy-level indicator values with 95% confidence intervals were calculated.

    • Main Results:

    • Pharmacies dispensed SABAs to an average of 328 patients.
    • Indicator 1 identified an average of 3.4% of SABA patients with potentially excessive supply.
    • Indicator 2 identified 8.2% of patients as SABA overusers, with 48% of these not receiving anti-inflammatory agents.

    Conclusions:

    • Quality indicators for asthma drug therapy can be feasibly applied at the individual pharmacy level using dispensing data.
    • These indicators highlight opportunities for improving the quality of asthma care.
    • Indicator 2, focusing on early refills of SABAs, is recommended for daily practice due to its ability to timely identify uncontrolled patients.